3W. G. Reeves,D. Barr,C. A. Douglas,K. Gelsthorpe,I. Hanning,A. Skene,L. Wells,R. M. Wilson,R. B. Tattersall. Factors governing the human immune response to injected insulin[J] 1984,Diabetologia(4):266～271
二级参考文献2
1Werner Waldh?usl,Kinga Howorka,Kurt Derfler,Paul R. Bratusch-Marrain,Claus Holler,Hillard Zyman,Heinrich Freyler. Failure and efficacy of insulin therapy in insulin dependent (type I) diabetic patients[J] 1985,Acta Diabetologica Latina(4):279～294
2M. Uusitupa,Onni Siitonen,K. Py?r?l?,A. Aro,K. Hersio,I. Penttil?,E. Voutilainen. The relationship of cardiovascular risk factors to the prevalence of coronary heart disease in newly diagnosed Type 2 (non-insulin-dependent) diabetes[J] 1985,Diabetologia(9):653～659
3Consensus Development Conference on Insulin Resistance. 5 - 6 November 1997. American Diabetes Association. Diabetes Care 1998(21 ) :310 -314.
4DeFronzo R A, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991 ( 14 ) : 173 - 194.
5Eckel R H, Grundy S M, Zimmet P Z. The metabolic syn- drome. Lancet 2005 (365) : 1415 - 1428.
6Fawcett J, Duckworth W C. Hyperglycaemia and hyperinsuli- naemia:is insulin -degrading enzyme the missing link? Diabetologia 2009 (52) : 1457 - 1460.
7Kitabchi A E, Stentz F B, Cole C, et al. Accelerated insulin degradation: an alt. ernate mechanism for insuiinresistance. Diabetes Care 1979(2) :414 -417.
8Kan C, Silva N, Golden S H, et al. A systematic review and meta - analysis of the associationbetween depression and insulin resist- ance. Diabetes Care 2013 ( 36 ) :480 - 489.
9Sato K, Takamatsu K, Hashimoto K. Short - term effects of octreotide on glucose tolerance in patients with acromegaly. Endocr J 1995 ; (42) :739 -745.
10Towns R,Kostyo J L,Colca J R. Pioglitazone inhibits the dia- betogenic action of growth hormone, but not its ability to promote growth. Endocrinology 1994(134) :608 -613.
